Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway

  • Authors:
    • Qiongqiong Liu
    • Yansong Huo
    • Hong Zheng
    • Jing Zhao
    • Li Jia
    • Peiguo Wang
  • View Affiliations

  • Published online on: May 30, 2019     https://doi.org/10.3892/or.2019.7176
  • Pages: 817-825
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As an inhibitor of high mobility group protein B1 (HMGB1), ethyl pyruvate (EP) has been associated with various inflammatory diseases. Recent studies have investigated the relationship between EP and cancer. The present study aimed to determine the antitumor efficacy of EP in non‑small cell lung cancer (NSCLC) cells and elucidate the underlying mechanism. A549, H520 and PC‑9 cells were treated with EP in suitable concentrations. RT‑qPCR and western blot analysis were performed to evaluate HMGB1 and RAGE expression levels. MTT and colony formation assays assessed the effect of EP on cell growth. A Transwell assay was used to evaluate invasion and migration potential and flow cytometry was performed to analyze cell apoptosis. Bcl‑2 family proteins were identified by western blot analysis. The results demonstrated that an increased EP concentration effectively reduced HMGB1 and RAGE expression, thus inhibiting the HMGB1/RAGE axis. EP decreased level of PCNA and MMP‑9 and increased P53 levels. Bcl‑2 and Mcl‑1 were also decreased, whereas Bax expression was increased. Furthermore, a high concentration of EP (30 mmol/l) significantly inhibited NF‑κB and STAT3 activation. In summary, EP inhibited NSCLC cell growth, invasion and migration and induced apoptosis by suppressing the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway, thus suggesting that EP may be a valuable therapeutic agent for NSCLC.

References

1 

Zou S, Pan X, Hua C, Wu M, He B and Chen Z: Myeloperoxidase-463 G/A polymorphism is associated with lung cancer risk: A meta-analysis with 7420 cases and 9132 controls. J Cancer Res Ther. 14 (Suppl):S282–S287. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Ziebarth NR: Lung cancer risk perception biases. Prev Med. 110:16–23. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Liu FT, Jia L, Wang P, Farren T, Li H, Hao X and Agrawal SG: CD126 and targeted therapy with tocilizumab in chronic lymphocytic leukemia. Clin Cancer Res. 22:2462–2469. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Park BS, Jo HW, Park C, Huh Y, Jung J and Jeong NY: A novel effect of ethyl pyruvate in Schwann cell de-differentiation and proliferation during Wallerian degeneration. Anim Cells Syst. 19:262–268. 2015. View Article : Google Scholar

5 

Li X, Jiang S and Tapping RI: Toll-like receptor signaling in cell proliferation and survival. Cytokine. 49:1–9. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Gruffaz M, Vasan K, Tan B, Ramos da Silva S and Gao SJ: TLR4-mediated inflammation promotes KSHV-induced cellular transformation and tumorigenesis by activating the STAT3 pathway. Cancer Res. 77:7094–7108. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Su X, Wang H, Zhao J, Pan H and Mao L: Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat. Mediators Inflamm. 2011:8071422012.

8 

Shao Y, Nanayakkara G, Cheng J, Cueto R, Yang WY, Park JY, Wang H and Yang X: Lysophospholipids and their receptors serve as conditional DAMPs and DAMP receptors in tissue oxidative and inflammatory injury. Antioxid Redox Signal. Apr 26–2017.(Epub ahead of print). doi: 10.1089/ars.2017.7069.

9 

Lin TJ, Lin HT, Chang WT, Mitapalli SP, Hsiao PW, Yin SY and Yang NS: Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components. Mol Cancer. 14:1742015. View Article : Google Scholar : PubMed/NCBI

10 

Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Klöting I, et al: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 50:2792–2808. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol. 14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Müller M, Morotti A and Ponzetto C: Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol. 22:1060–1072. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L and Karin M: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Shen Y, Devgan G, Darnell JE Jr and Bromberg JF: Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci USA. 98:1543–1548. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Pathak M, Mishra R, Agarwala PK, Ojha H, Singh B, Singh A and Kukreti S: Binding of ethyl pyruvate to bovine serum albumin: Calorimetric, spectroscopic and molecular docking studies. Thermochim Acta. 633:140–148. 2016. View Article : Google Scholar

17 

Cook VL, Holcombe SJ, Gandy JC, Corl CM and Sordillo LM: Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes. Vet Immunol Immunopathol. 141:92–99. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Wagner N, Dieteren S, Franz N, Köhler K, Mörs K, Nicin L, Schmidt J, Perl M, Marzi I and Relja B: Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release. PLoS One. 13:e0192171doi: 10.1371/journal.pone.0192171. eCollection. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Wang FC, Xie Y and Zhou NJ: Ethyl pyruvate reduced h pylori- induced inflammation through inhibition of HMGB1/TLR4 pathways. J Gastroenterol Hepatol. 29:27. 2014.

20 

Shen HX, Hu XM, Liu C, Wang SP, Zhang WT, Gao H, Steder RA, Gao YQ and Chen J: Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiol Dis. 37:711–722. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Shen M, Lu J, Dai W, Wang F, Xu L, Chen K, He L, Cheng P, Zhang Y, Wang C, et al: Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy. Mediators Inflamm. 2013:4615362013. View Article : Google Scholar : PubMed/NCBI

22 

Chakhtoura M, Chain R, Varghese L and Gallucci S: Ethyl pyruvate, an inhibitor of high-mobility group box 1 (HMGB1) release, modulates dendritic cell activation and survival (TRAN3P.897). J Immunol 192 (1 Suppl). S202–S236. 2014.

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2011. View Article : Google Scholar

24 

Ibrahim ZA, Armour CL, Phipps S and Sukkar MB: RAGE and TLRs: Relatives, friends or neighbours? Mol Immunol. 56:739–744. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Han SH, Kim YH and Mook-Jung I: RAGE: The beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells. 31:91–97. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 8:49–62. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Actis M, Inoue A, Evison B, Perry S, Punchihewa C and Fujii N: Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis. Bioorg Med Chem. 21:1972–1977. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Abike F, Tapisiz OL, Zergeroglu S, Dunder I, Temizkan O and Payasli A: PCNA and Ki-67 in endometrial hyperplasias and evaluation of the potential of malignancy. Eur J Gynaecol Oncol. 32:77–80. 2011.PubMed/NCBI

31 

Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW and Muschel RJ: Metalloproteinases in tumor progression: The contribution of MMP-9. Invasion Metastasis. 14:246–258. 1994.PubMed/NCBI

32 

Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, Noonan DM, Natali PG and Albini A: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer. 87:336–342. 2000. View Article : Google Scholar : PubMed/NCBI

33 

Farina AR and Mackay AR: Gelatinase B/MMP-9 in tumour pathogenesis and progression. Cancers (Basel). 6:240–296. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Zhang L, Ma L, Yan T, Han X, Xu J, Xu J and Xu X: Activated mitochondrial apoptosis in hESCs after dissociation involving the PKA/p-p53/Bax signaling pathway. Exp Cell Res. 369:226–233. 2018. View Article : Google Scholar : PubMed/NCBI

35 

Yao TH, Pataer P, Regmi KP, Gu XW, Li QY, Du JT, Ge SM and Tu JB: Propranolol induces hemangioma endothelial cell apoptosis via a p53-BAX mediated pathway. Mol Med Rep. 18:684–694. 2018.PubMed/NCBI

36 

Youle RJ and Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Zhang J, Zhu JS, Zhou Z, Chen WX and Chen NW: Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep. 27:1511–1519. 2012.PubMed/NCBI

38 

Birkenmeier G, Hemdan NYA, Kurz S, Bigl M, Pieroh P, Debebe T, Buchold M, Thieme R, Wichmann G and Dehghani F: Ethyl pyruvate combats human leukemia cells but spares normal blood cells. PLoS One. 11:e01615712016. View Article : Google Scholar : PubMed/NCBI

39 

Pellegrini L, Xue J, Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, et al: HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget. 8:22649–22661. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Cheng P, Dai W, Wang F, Lu J, Shen M, Chen K, Li JJ, Zhang Y, Wang C, Yang J, et al: Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochem Biophys Res Commun. 443:1162–1168. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Baunacke M, Horn LC, Trettner S, Engel KM, Hemdan NY, Wiechmann V, Stolzenburg JU, Bigl M and Birkenmeier G: Exploring glyoxalase 1 expression in prostate cancer tissues: Targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties. Prostate. 74:48–60. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Li ML, Wang XF, Tan ZJ, Dong P, Gu J, Lu JH, Wu XS, Zhang L, Ding QC, Wu WG, et al: Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis. Int J Immunopathol Pharmacol. 25:955–965. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Queisser MA, Kouri FM, Königshoff M, Wygrecka M, Schubert U, Eickelberg O and Preissner KT: Loss of RAGE in pulmonary fibrosis: Molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol. 39:337–345. 2008. View Article : Google Scholar : PubMed/NCBI

44 

Xu X, Zhu H, Wang T, Sun Y, Ni P, Liu Y, Tian S, Amoah Barnie P, Shen H, Xu W, et al: Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways. Scand J Immunol. 79:386–394. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Gilmore TD: Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006. View Article : Google Scholar : PubMed/NCBI

46 

Escárcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A and Zamora A: The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol). 19:154–561. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Yuan ZL, Guan YJ, Wang L, Wei W, Kane AB and Chin YE: Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol. 24:9390–9400. 2004. View Article : Google Scholar : PubMed/NCBI

48 

Bennett-Guerrero E, Swaminathan M, Grigore AM, Roach GW, Aberle LG, Johnston JM and Fink MP: A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 23:324–329. 2009. View Article : Google Scholar : PubMed/NCBI

49 

Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, et al: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August 2019
Volume 42 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, Q., Huo, Y., Zheng, H., Zhao, J., Jia, L., & Wang, P. (2019). Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway. Oncology Reports, 42, 817-825. https://doi.org/10.3892/or.2019.7176
MLA
Liu, Q., Huo, Y., Zheng, H., Zhao, J., Jia, L., Wang, P."Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway". Oncology Reports 42.2 (2019): 817-825.
Chicago
Liu, Q., Huo, Y., Zheng, H., Zhao, J., Jia, L., Wang, P."Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway". Oncology Reports 42, no. 2 (2019): 817-825. https://doi.org/10.3892/or.2019.7176